Glenmede Trust’s Confluent CFLT Stock Holding History

Glenmede Trust’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,923	Closed	-$201K	–	1301
2022 Q1	$201K	Sell	4,923 -644	-12%	-$33.6K	﹤0.01%	1136
2021 Q4	$424K	Buy	+5,567	New	+$401K	﹤0.01%	967

Other funds holding CFLT

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Glenmede Trust's CFLT Position: Q2 2022 in Review

Glenmede Trust sold out of Confluent (CFLT) in Q2 2022, closing a stake of 4,923 shares — an estimated $201K sold.

Glenmede Trust first reported a position in CFLT in Q4 2021 and held it in 2 quarters. The position peaked at $424K in Q4 2021. 200 funds tracked by Wall St. Rank hold CFLT as of Q2 2022.

Glenmede Trust reported no remaining Confluent position as of Q2 2022 after selling out during the quarter.
Glenmede Trust sold 4,923 Confluent shares in Q2 2022, an estimated $201K.
Glenmede Trust first reported a position in Confluent in Q4 2021 and held it in 2 quarters.
Glenmede Trust's Confluent position peaked at $424K in Q4 2021.
200 funds tracked by Wall St. Rank held Confluent as of Q2 2022.

Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.